[CAS NO. 52-90-4] L-Cysteine
PRODUCTS SPECIFICATIONS [52-90-4]
DESCRIPTION [52-90-4]
Overview
| MDL | MFCD00064306 |
|---|---|
| Molecular Weight | 121.16 |
| Molecular Formula | C3H7NO2S |
| SMILES | N[C@@H](CS)C(O)=O |
Summary
L-Cysteine is a conditionally essential amino acid, which acts as a precursor for biologically active molecules such as hydrogen sulphide (H2S), glutathione and taurine. L-Cysteine suppresses ghrelin and reduces appetite in rodents and humans [1] .
IC50 & Target
|
Human Endogenous Metabolite |
Microbial Metabolite |
Clinical Trial
| NCT Number | Sponsor | Condition | Start Date | Phase |
|---|---|---|---|---|
| NCT02462746 | Centre for Addiction and Mental Health |
Healthy
|
March 2015 | Phase 1 |
| NCT02524262 | Per Hellström|Biohit Oyj, Helsinki, Finland|University of Helsinki|�bo Akademi University|CTC Clinical Trial Consultants AB|Uppsala University |
Gastritis, Atrophic
|
December 2012 | Phase 2 |
| NCT02050139 | Mario Negri Institute for Pharmacological Research|Bio3 Research s.r.l. - Milan Italy |
Uremia
|
February 2014 | Phase 2 |
| NCT04939792 | Louisiana State University Health Sciences Center Shreveport |
Vitamin D Deficiency
|
November 6, 2020 | Early Phase 1 |
Appearance
Solid
Shipping
Room temperature in continental US; may vary elsewhere.
Storage
| Powder | -20°C | 3 years |
|---|---|---|
| 4°C | 2 years | |
| In solvent | -80°C | 6 months |
| -20°C | 1 month |
Solvent & Solubility
H 2 O : 33.33 mg/mL ( 275.09 mM ; Need ultrasonic)
Stock Solutions
| Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
|---|
| 1 mM | 8.2535 mL | 41.2677 mL | 82.5355 mL |
| 5 mM | 1.6507 mL | 8.2535 mL | 16.5071 mL |
| 10 mM | 0.8254 mL | 4.1268 mL | 8.2535 mL |
-
1.
Add each solvent one by one: PBS
Solubility: 100 mg/mL (825.35 mM); Clear solution; Need ultrasonic
Synonyms